19 October 2015 | Geneva −− Three countries of WHO’s South-East Asia Region – Bangladesh, India and Nepal – are poised to eliminate visceral leishmaniasis (kala-azar) as a public health problem. The number of cases has reduced by 53%, from a high of 182 000 cases during 2005–2008 to 85 000 cases during 2011–2014. The 10 209 new cases reported in 2014 represents a 75% decrease from 2005 when the Kala-Azar Elimination Programme was launched.
16 January 2015 | Geneva −− WHO is and has been making efforts to coordinate and provide support to strengthen leishmaniasis control in various countries in the Maghreb, Middle East, Eastern Europe and Central Asia.
The leishmaniases are a group of diseases caused by protozoan parasites from more than 20 Leishmania species that are transmitted to humans by the bites of infected female phlebotomine sandflies.
There are three main forms of the disease: cutaneous leishmaniasis, visceral leishmaniasis or kala-azar, and mucocutaneous leishmaniasis.
300 000Estimated cases of visceral leishmaniasis (VL) and over 20 000 deaths annuallyVisceral leishmaniasis -- status of endemicity and disease burden worldwide, 2013
1 millionCases of cutaneous leishmaniasis (CL) reported in the last 5 years.Cutaneous leishmaniasis -- status of endemicity and disease burden worldwide, 2013
310 millionPeople at risk of infection in six countries reporting over 90% VL cases worldwide.Third WHO report on NTDs
Chapter 4.9, page 118–126